With at least 611 systems sold in 2025, China’s surgical robot market is shifting from concept-driven growth to structured, clinically led expansion across multiple surgical specialties.

In 2025, 52 NMPA approvals were granted to surgical robots developed by Chinese companies, including both new systems and indication expansions. Orthopedics accounted for the largest share, with 23 approvals.

China’s orthopedic surgical robot market reached at least 168 units in 2025, with domestic manufacturers leading the field and the industry entering a phase of rapid commercialization and clear differentiation.

Based on public hospital procurement disclosures, this report reviews 90 laparoscopic surgical robot awards in China in 2025, highlighting vendor concentration and evolving hospital adoption trends.

This report summarizes MedChina’s consolidated count of at least 313 surgical robotic systems sold or installed in 2024, based on public procurement records and partial manufacturer data.